This document summarizes hot topics in intensive care medicine that were presented by Steve Mathieu. It includes summaries of recent studies on ARDS treatments like HFOV, prone positioning, and statins. Guidelines on standards of care, tracheostomy procedures, blood transfusion, and AF management are reviewed. Recent studies on early versus late tracheostomy timing (TracMan) and HFOV versus conventional ventilation (OSCAR, OSCILLATE) in ARDS are summarized. The NAP4 study on airway complications in ICUs and operating rooms is also highlighted.
Hot Topics in ICM - PINCER Course 25th sept 2015Steve Mathieu
Presentation by Steve Mathieu @stevemathieu75
Hot Topics presentation from Portsmouth INtensive Care Exam Revision (PINCER) Course http://www.wessexics.com/Wessex_ICM_Courses/PINCER_FFICM_Revision_Course/
Hot Topics in ICM - PINCER Course 25th sept 2015Steve Mathieu
Presentation by Steve Mathieu @stevemathieu75
Hot Topics presentation from Portsmouth INtensive Care Exam Revision (PINCER) Course http://www.wessexics.com/Wessex_ICM_Courses/PINCER_FFICM_Revision_Course/
Evidence Based Medicine in Prehospital ResuscitationSMACC Conference
Marius Rehn examines the difficulties and importance of evidence based medicine in prehospital resuscitation. Notably, combining academic activity with pre- and in-hospital clinical practice is hard work. Being an academic in a flight suit can be quite lonely.
Marius wants this to change and is passionate about increasing the quantity and quality of prehospital research.
Prehospital research that examines patient pathophysiology should dictate care – as it does in the hospital environment. However, Evidence based practice pertaining to the prehospital environment is minimal. This needs to change.
Evidence based medicine in the prehospital setting can dictate care, critically appraise practice and enable improvements in process and cost effectiveness whilst decreasing harms.
Evidently, in-hospital evidence is different to the field application. Ultimately, prehospital research is critical, 5.8 million people die from injury every year – around 10% of the world’s deaths. Unfortunately, pre-hospital research is underfunded.
So, how can we take interventions from the hospital to the streets?
Marius shares three important steps:
The research that is needed
How to interpret the evidence
Why all research is important to consider (from case studies to randomised controlled trials)
Moreover, Marius highlights the need to lean on other members of the scientific community when conducting your own research. For example, a statistician is worth their weight in gold in observational studies when fleshing out regression analysis.
Finally, Marius discusses the importance of information dissemination across all platforms, including peer reviewed journals and informal FOAMed platforms such as Twitter. They all have their place.
For more like this, head to our podcast page. #CodaPodcast
BCC4: Michael Parr on ICU - Surviving Trauma GuidelinesSMACC Conference
Michael Parr, director of Liverpool ICU in Australia, speaks about "Surviving Trauma Guidelines". He does so through the use of an interesting case of a patient admitted to ICU following a MVA. This educational podcast was recorded at BCC4.
Delaney shares insights into the mysterious world of statistics and trials. This 12 minute podcast is particularly useful for Registrars preparing for their exams and was recorded at BCC4. For similar podcasts and audio; head to www.intensivecarenetwork.com and to rego for BCC5 in Cairns, check out www.bedsidecriticalcare.com
Presentation by Dr Jason Wu - resident in Critical Care at TWH, for the critical care journal club report findings of a paper by Kaukonen KM, et al. N Engl J Med. 2015 & update from the recent SMACC conference in Chicago #FOAMed #SMACC (http://www.ncbi.nlm.nih.gov/m/pubmed/25776936/)
Pharmacological management of cerebral vasospasm in subarachnoid hemorrhagePrisma Health Upstate
Medical management of vasospasm in subarachnoid hemorrhage patients. Despite targeting multiple pathophysiological mechanisms of DCI and vasospasm, most of the trials did not yield results that could translate to clinical practice. Fasudil and emerging therapies like cisternal irrigation and lumbar drainage combined with intrathecal vasodilators and phosphodiesterase medications showed promising results but need to be tested in a randomized clinical trial for effectiveness.
Evidence Based Medicine in Prehospital ResuscitationSMACC Conference
Marius Rehn examines the difficulties and importance of evidence based medicine in prehospital resuscitation. Notably, combining academic activity with pre- and in-hospital clinical practice is hard work. Being an academic in a flight suit can be quite lonely.
Marius wants this to change and is passionate about increasing the quantity and quality of prehospital research.
Prehospital research that examines patient pathophysiology should dictate care – as it does in the hospital environment. However, Evidence based practice pertaining to the prehospital environment is minimal. This needs to change.
Evidence based medicine in the prehospital setting can dictate care, critically appraise practice and enable improvements in process and cost effectiveness whilst decreasing harms.
Evidently, in-hospital evidence is different to the field application. Ultimately, prehospital research is critical, 5.8 million people die from injury every year – around 10% of the world’s deaths. Unfortunately, pre-hospital research is underfunded.
So, how can we take interventions from the hospital to the streets?
Marius shares three important steps:
The research that is needed
How to interpret the evidence
Why all research is important to consider (from case studies to randomised controlled trials)
Moreover, Marius highlights the need to lean on other members of the scientific community when conducting your own research. For example, a statistician is worth their weight in gold in observational studies when fleshing out regression analysis.
Finally, Marius discusses the importance of information dissemination across all platforms, including peer reviewed journals and informal FOAMed platforms such as Twitter. They all have their place.
For more like this, head to our podcast page. #CodaPodcast
BCC4: Michael Parr on ICU - Surviving Trauma GuidelinesSMACC Conference
Michael Parr, director of Liverpool ICU in Australia, speaks about "Surviving Trauma Guidelines". He does so through the use of an interesting case of a patient admitted to ICU following a MVA. This educational podcast was recorded at BCC4.
Delaney shares insights into the mysterious world of statistics and trials. This 12 minute podcast is particularly useful for Registrars preparing for their exams and was recorded at BCC4. For similar podcasts and audio; head to www.intensivecarenetwork.com and to rego for BCC5 in Cairns, check out www.bedsidecriticalcare.com
Presentation by Dr Jason Wu - resident in Critical Care at TWH, for the critical care journal club report findings of a paper by Kaukonen KM, et al. N Engl J Med. 2015 & update from the recent SMACC conference in Chicago #FOAMed #SMACC (http://www.ncbi.nlm.nih.gov/m/pubmed/25776936/)
Pharmacological management of cerebral vasospasm in subarachnoid hemorrhagePrisma Health Upstate
Medical management of vasospasm in subarachnoid hemorrhage patients. Despite targeting multiple pathophysiological mechanisms of DCI and vasospasm, most of the trials did not yield results that could translate to clinical practice. Fasudil and emerging therapies like cisternal irrigation and lumbar drainage combined with intrathecal vasodilators and phosphodiesterase medications showed promising results but need to be tested in a randomized clinical trial for effectiveness.
Hergen Buscher is an Intensivist from St Vincent's hospital in Sydney. He has extensive experience with ECMO, in both veno-venous and veno-arterial contexts. Listen to this talk he gave on the most recent developments in ECMO and where things are heading.
This talk was given live in September 2014 for an Intensive Care Network (ICN) NSW meeting.
Go to www.intensivecarenetwork.com for more.
Acute pulmonary embolism - risk stratification and managementPrithvi Puwar
what is the guideline recommendation and ideal to be done in management of acute pulmonary embolism. the presentation includes risk stratification, recommendation and approach to investigations (guidelines based) and management options with evidence.
Physician should have a high suspicion to diagnose patient with pulmonary Embolism, this slides will give you precise Diagnosis, Investigation and guideline directed Treatment.
When to dialyse a patient and with what modality of dialysis will be topic of discussion.The recent advances and debates surrounding the topic will be discussed in detail
Extracorporeal membrane oxygenation assisted cardiopulmonary resuscitation (ECPR) is an effective therapy to improve outcomes for children who experience cardiopulmonary arrest. Survival after ECLS varies between 60% and 75%. For ECPR survival is lower, with 40% to 50% of children surviving ECPR. After ECPR good neurological outcomes are seen in 40% to 60% of children. This contrasts with adult patients where neurological outcomes after ECPR are poor. Given these findings the American Heart Association has included ECPR in their 2015 guidelines for children who experience an in hospital cardiac arrest (IHCA).
PICUDoctor.org is a medical reference e-book that covers the evolving knowledge in physiology and pathophysiology of pediatric cardiac critical care. From preoperative, perioperative and postoperative management through specific topics in critical care treatment, anaesthesia and analgesia, pharmacokinetics and pharmacodynamics, heart failure, circulatory mechanical assist and ECMO, the electronic format of PICUDoctor.org incorporates and allows implementation of up to date knowledge with multimedia.
PICUDoctor.org was first developed in 2011 with contributions from authors around the world. Further edits and the transition to an online e-book followed in 2013 and 2014. Initially a bedside tool, it evolved into a full reference e-textbook with multiple multi-media functions as well as links to PubMed® articles to further support the users’ education. PICUDoctor.org is a not peer reviewed, but open source. To limit costs for publication and distribution, PICUdoctor.org is available in portable document format, iTunes and Google https://www.facebook.com/picudoctor.org/ for more details.
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practicebgander23
A 2 part presentation. Part 1 reviews a paper on the long-term clinical outcomes of STEMI patients undergoing remote ischaemic perconditioning prior to primary percutaneous coronary intervention. The 2nd part looks at how this technique can be used in Paramedic practice.
Pancreas summary from 12th Banff Conference on Transplant Pathology from the meeting in Comandatuba-Bahia, Brazil on August 23rd, 2013 http://cybernephrology.ualberta.ca/banff/2013
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Couples presenting to the infertility clinic- Do they really have infertility...
Pincer 12th sept2014 1
1. Hot
Topics
in
ICM
Steve
Mathieu
Consultant
in
Intensive
Care
Medicine
Queen
Alexandra
Hospital,
Portsmouth
12th
September
2014
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
2. Hot
Topics/QuesCon
spoDng
• Syllabus
• Examiners
report
• Review
arCcles
&
key
papers
–
JICS
• Guidelines
• Review
FICM
&
ICS
websites
• CriCcal
Eye
• Other
resources
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
7. Original
Ar4cles
Reviews
Case
reports
CAT
reviews
Others
July
2014
Echo
in
PE
Quality
(pressure
ulcers)
DKA
Acute
mesenteric
ischaemia
Epidural
abscess
JW
GI
haemorrhage
Mixed
OD
Acromegaly
StaCn
&
VAP
SEPSISPAM
ProtecCve
venClaCon
in
abdominal
surgery
Heart
rate
control
in
sepCc
shock
Delirium
April
2014
Tracheostomy
VAP
Improving
Cmeliness
of
Cme-‐criCcal
transfers
HIT
HepaCCs
B
&
C
SedaCon
Electrical
muscle
sCmulaCon
in
ICU
(CIPN)
HD
for
dabigatran
associated
coagulopathy
Wernickes
PaCent
with
tetanus
TBI
Hope
ICU
(delirium)
CSL
or
HES
TTM
Prone
venClaCon
Capnography
Jan
2014
COMET-‐UK
(CO
monitoring)
Tracheostomy
Right
heart
failure
StabilisaCon
and
transport
of
criCcally
ill
child
ECG
and
trauma
Rhabdomyolysis
PancreaCCs
MDMA
toxicity
Hyperthyroidism
Pulmonary
haemorrhage
and
AKI
TracMan
AKI
Organ
donaCon
Surveillance
for
VAP
PE
supplement
October
2013
Echo
NAVA
venClaCon
Pain
Brainstem
tesCng
Plasma
exchange
in
HUS
Intralipid
in
felodipine
toxicity
Tracheostomy
Transfusion
strategies
for
upper
GI
bleed
Prone
TXA
Survey
on
rehab
aeer
criCcal
illness
Echo
in
UK
Blood
transfusion
in
ICU
BIS
monitoring
Faecal
inconCnence
in
ICU
July
2013
Noise
level
in
ICU
(delirium)
Serious
Hazards
of
Transfusion
(SHOT)
Medical
support
for
heart
failure
PCT
NO
OTC
deficiency
Hyperkalaemia
in
HIV
paCent
with
‘PCP’
ICP
monitoring
SedaCon
Gentamycin
&
vancomycin
Ancillary
tests
in
diagnosis
of
brainstem
tesCng
LCP
9. Standards
-‐
quality
• Staffing
– Consultant
presence
• 24/7
&
within
30
minutes
– Consultant:
paCent
1:8
–
1:15;
ICU
resident/
paCent
1:8
– Designated
CD
– Ward
rounds
x2
daily
– Training
/
FICM
/
Board
Tutors
– Nursing
1:1
(level
3);
1:2
(level
2)
– MDT
e.g.
physio,
pharmacy,
dieCcians
• Opera4onal
– Large
ICUs
divided
into
pods
of
8-‐15
paCents
– Admit
within
4
hrs
of
decision
to
admit
– Avoid
non-‐clinical
transfers
– Transfer
to
ward
–
clear
and
formalised
– Out
of
hours
transfers
– Readmission
within
48
hours
bad
– Assessment
of
rehab
for
each
paCent
• Equipment
– Training
• Data
Collec4on
– ICNARC
– Risk
register
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
10. NCEPOD
2014:
Tracheostomy
• DocumentaCon
&
consent
– IndicaCons,
type,
inner
tube,
reasons
for
failed
extubaCon/why
no
trial
of
extubaCon
• Different
types
of
tubes
• Rapidly
available
difficult
airway
trolley
• Training
programmes
in
blocked/displaced
tubes
• Capnography
• Discharge
of
paCents
with
tracheostomy
• MDT
–
physio
&
SALT
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
11. Tracheostomy
standards
ICS
• IndicaCons
for
tracheostomy
• CauCons
and
contraindicaCons
• Consent
• Equipment
• Ultrasound
• Anaesthesia
• Staffing
• Types
of
tracheostomy
tubes
• Inner
cannulae
• ComplicaCon
– Early
– Late
– Airway
emergencies
12. Guidelines
• Blood
transfusion
– ABLE
MulCcentre
UK
RBC
transfusion
(7d
vs.
15-‐25d)
– Transfusion
triggers
–
TRICC
&
Villaneuva
– Guidelines
on
the
management
of
anemia
and
RBC
transfusion
in
adult
criCcally
ill
paCents
h"p://www.bcshguidelines.com/documents/BCSH_Cri;cal_Care_Guidelines_Final_Version_22_10_12.pdf
– Serious
Hazards
of
Transfusion
(SHOT)
–
JICS
July
2013
• CalculaCon
of
Cerebral
Perfusion
Pressure
• AF
management
–
NICE
&
JICS
• Clinical
Guidelines
on
management
of
pain,
agitaCon
and
delirium
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
13. Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
• Transfusion
Triggers
• Blood
conservaCon
• Pre-‐transfusion
clinical
assessment
• Rate
of
transfusion/fluid
balance
• InvesCgaCon
adverse
events
• Storage
duraCon
18. CriCcal
Eye
No
6:
Core
standards
Examiners
report
No
5:
FICM
ConsultaCons:
IV
fluids
(NICE
–
IV
therapy
in
adults
in
hospital
Dec
2013)
Head
injury
&
specialist
centres
Quality
–
quality
indicators?
No
4:
1st
Examiners
report
–
March
2013
19. The
key
papers
in
CriCcal
Care
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
20. NAP
4
-‐
2011
• All
NHS
hospitals
for
1
year
’08-‐’09
• 184
reports
" 133
anaesthesia
" 36
ICU
" 15
ED
• Inclusion
criteria
" death,
brain
damage
" emergency
surgical
airway
" unanCcipated
ICU
admission
" ProlongaCon
ICU
stay
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
21. Summary
of
NAP
4
" 25%
of
major
airway
events
in
a
hospital
occur
in
ICU
or
the
ED
" 46%
of
ICU
events
and
53%
of
ED
events
occurred
out
of
hours
" 50%
of
ICU
events
were
due
to
tracheostomy
related
events
" 50%
events
in
ICU
and
27%
events
in
ED
resulted
in
death
" 61%
events
in
ICU
resulted
in
death
or
severe
neurological
harm
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
22. RecommendaCons
" Capnography
" Airway
equipment
" Back
up
planning
" Staffing
" PaCent
transfers
" EducaCon/training
" Tracheostomy
tube
design
" Team
working
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
23. TracMan
• 909
intubated
paCents
• Respiratory
failure
– <
4
days
– Predicted
to
need
MV
for
further
7
days
• Tracheostomy
Cming
• Early
(≤
4
days)
vs
late
(aeer
10
days)
• No
difference
in
– 30/7Mortality;
ICU
LOS;
ComplicaCons
• Only
45%
late
group
received
Academic Department of Critical Care
trache
Queen Alexandra Hospital Portsmouth
24. OSCAR
• 795
paCents
with
moderate
-‐
severe
ARDS
(<26.7kPa
/
200mmHg)
• CMV
vs.
HFOV
(MV
<7
days)
• No
difference
in
– 30/7
mortality
(41%)
– DuraCon
anCmicrobial
agents
(2/3
chest
sepsis)
– VasoacCve
support
duraCon
– ICU
LOS
– Hospital
LOS
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
25. OSCILLATE
• 548
paCents
with
moderate
-‐
severe
ARDS
• HFOV
vs
low
Vt/High
PEEP
CV
(MV
<
3d)
• Trial
stopped
early
as
harm
with
HFOV
• HFOV
– Hospital
mortality
47%
vs
35%
– More
sedaCon
– More
NMBA’s
– More
vasopressors
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
26. Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
OSCAR
OSCILLATE
29
ICU’s
UK
39
ICU’s
5
countries
795
paCents
548
paCents
(planned
1200)
PaO2:FiO2
<
200mmHg
Bilateral
pulmonary
infiltrates
MV
for
LESS
than
7
consecuCve
days
at
the
point
of
randomisaCon
PaO2:FiO2
<
200mmHg
FiO2
>
0.5
Bilateral
pulmonary
infiltrates
MV
for
LESS
than
3
consecuCve
days
at
the
point
of
randomisaCon
Encouraged
to
use
PC
6-‐8mls/kg
and
use
ARDS
protocol
for
FiO2
&
PEEP
R
100
venClator
PEEP
11
CV
–
PC
6mls/kg,
3100
B
venClator
Recruitment
maneuvers
before
HFOV
Protocol
specified
high
PEEP
for
CV
(PEEP
13)
30d
mortality
42%
vs.
41%
(HFOV
vs.
CV)
30d
mortality
40%
vs.
29%
Hospital
mortality
47%
vs.
35%
(HFOV
vs.
CV)
More
NMBA’s
More
midazolam,
vasoacCve
drugs,
NMBA’s
in
HFOV
Lower
PEEP
strategy
?
recruitment
maneuvers
of
lung
before
HFOV
injurious
Mortality
41%
in
control
group
Mortality
35%
in
control
group
27. PROSEVA
• 466
paCents
with
severe
ARDS
• Prone
posiCon
vs
supine
posiCon
• Prone
posiCon
was
associated
with
– Improved
mortality
• 28
day:
16%
vs
33%
• 90
day:
24%
vs
41%
– Less
cardiac
arrests
– No
difference
in
complicaCons
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
29. ARDS
-‐
lots
of
trials
" HFOV
" Nitric
Oxide
" Surfactant
" Perflourocarbon
"
" Late
steroids
(LaSRS)"
" Prostaglandin
E1
"
" Lysophylline
(LARMA)"
" Ketoconazole
(KARMA)
" Streptokinase
" StaCns
(HARP
2,
SAILS)
"
" Neutrophil
elastase
inhibitor
"
" ImmunonutriCon
(Eden-‐
Omega)"
" rhAPC
"
" Albuterol/salmeterol
(BALTI
I
&
II,
ALTA)
"
" Lower
Vt
!
" ?
Furosemide
(FACTT)
!
" Cisatricurium
" Prone
‘back’
in
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
30. BALTI
-‐
2012
• 162
paCents;
46
UK
ICU’s
• ARDS
&
MV
-‐
salbutamol
15mcg/kg/hr
or
placebo
-‐ Treatment
for
up
to
7
d
• Mortality
greater
in
those
given
salbutamol
34%
vs
23%
at
28d
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
31. StaCns
in
ARDS
• MulCcentre,
RCT
• RosuvastaCn
vs.
placebo
in
ARDS
• StaCn
may
modulate
inflammatory
response
• 745
paCents
(trial
stopped
early
because
of
fuClity)
• Primary
outcome:
• 60d
mortality:
28.5%
vs.
24.9%
(staCn
vs.
placebo)
• VenClator
free
days:
15.1
vs.
15.1
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
32. StaCn
&
VAP
• 300
paCents
with
suspected
VAP
(CPIS
≥
5)
• SimvastaCn
60mg
vs
placebo
• No
difference
in
– 28d
survival
– ICU
or
hospital
mortality
– DuraCon
MV
– Delta
SOFA
• Increased
mortality
in
staCn
naieve
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
33. Magnesium
in
asthma
• 1200
paCents
2008-‐2012
• Neb
vs.
IV
Mg
vs.
placebo
• No
role
for
neb
Mg
• Limited
role
at
best
for
IV
Mg
• Not
life
threatening
asthma
Intravenous
or
nebulised
magnesium
sulphate
versus
standard
therapy
for
severe
acute
asthma
(3Mg
trial):
a
double-‐
blind,
randomised
controlled
trial
Goodacre
et
al
Lancet
2013
Vol
1
(4)
293-‐300
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
34. Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
• Meta-‐analysis
• 16
trials
inc
PEITHO,
MAPPETT,
MOPETT,
TOPCOT
• Thrombolysis
+
anCcoagulaCon
vs.
anCcoagulaCon
alone
• All
cause
mortality
less
in
thrombolysis
group
but
major
bleeding
&
ICH
higher
35. TTM
• 950
unconscious
adults;
36
ICU’s
• 33°C
(n=473)
with
36°C
(n=466)
• No
difference
in
– All
cause
mortality
33°C
(50%)
with
36°C
(48%)
– poor
neurological
func4on
at
180
days
33°C
(54%)
with
36°C
(52%)
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
36. Pre-‐hospital
hypothermia
• Prehospital
cooling
vs.
standard
care
• 2L
of
cold
normal
saline
once
ROSC
• 1,359
OOHCA
paCents
• Cooling
effecCve
(reduced
temp)
• No
difference
– Survival
to
hospital
discharge
•
VF
63%
vs
64%
•
nonVF
19%
vs
16%
– Good
neurological
recovery
• VF
57%
vs
62%
• nonVF
14%
vs
13%
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
37. IABP
–
SHOCK
II
• 600
paCents
with
cardiogenic
shock
secondary
to
AMI
• IABP
vs
no
IABP
• All
received
early
revascularisaCon
and
best
medical
therapy
• No
difference
– 30/7
mortality
(40%)
– ICU
LOS,
catecholamine,
bleeding
• Lancet
2013
Sept
–
12/12
results
=
no
difference
in
mortality
or
reinfarcCon
rate
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
38. VSE
in
cardiac
arrest
• 268
paCents
in
hospital
cardiac
arrest
• Vasopressin(20IU/CPR
cycle)
+
epinephrine
(1mg/CPR
cycle)
+
methylprednisilone
(40mg)
vs
placebo
+
epinephrine
(1mg/CPR
cycle)
• VSE
group
– ROSC
at
20
mins
higher
84%
vs
66%
– Improved
survival
to
hospital
discharge
with
CPC
1
or
2
– Improved
haemodynamics
&
cvSpO2
– Less
organ
dysfuncCon
Aca•d eamndic
Department of Critical Care
Queen Alexandra Hospital Portsmouth
40. Ferrer:
Empiric
anCbioCcs
in
sepsis
• RetrospecCve
observaConal
cohort
study
• 165
ICUs
–
Europe,
US
&
S
America
• Jan
2005-‐
Feb
2010
• 18,000
paCents
with
sepCc
shock
• Delay
in
anCbioCcs
administraCon
over
first
6
hours
aeer
idenCficaCon
of
SS
or
sepCc
shock
-‐>
increased
mortality
• <
1
hr
24.6%;
1-‐2h
25.9%
>
6h
33%
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
41. SEPSISPAM
• RCT,
mulCcentre,
29
French
ICUs
• March
2010
–
Dec
2011
• SepCc
shock
• Target
MAP
80-‐85
vs.
65-‐70
• No
difference
in
– 28
day
mortality
(high
MAP
36.6%
vs.
34%)
• New
AF
6.7%
in
higher
MAP
group
vs.
2.8%
P=0.02
• In
chronic
hypertension
group,
worsening
creaCnine
and
need
for
RRT
was
lower
in
higher
MAP
group
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
42. OPTIMISE
• RCT,
mulCcentre,
17
UK
ICUs
• 734
paCents
• >
50y
undergoing
GI
surgery
with
one
or
more
‘high
risk’
risk
factors
• Algorithm-‐directed
care
dictaCng
colloid
and
dopexamine
administraCon
using
vs.
clinician
directed
care
without
use
of
CO
monitoring
• Primary
outcome:
composite
of
30d
mortality
and
mod/major
complicaCons
– IntervenCon:
36.6%
– Control
arm:
43.4%
• No
SS
difference
in
secondary
outcomes
– POMS,
infecCous
complicaCons,
criCcal
care
free
days
at
30d,
mortality
at
30d
and
180d,
hospital
LOS
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
43. PROWESS
SHOCK
• Randomised,
controlled,
mulCcentre,
parallel
group
study
• 1,697
paCents
with
sepCc
shock
• No
difference
in
– 28
day
mortality
(APC
26.4%
vs
24.2%)
– 90
day
mortality
(34.1%
vs
32.7%)
• No
subgroup
effect
seen
in
protein
C
deficient
group
• Serious
bleeding
n
=
10
APC
vs
8
placebo
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
44. VANISH
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
Vasopressin
&
corCcosteroids
in
SepCc
Shock.
A
Pilot
Study
–
Gordon
A,
2014
HydrocorCsone
-‐
vasopressin
sparing
-‐
reduced
duraCon
vasopressin
-‐
reduced
dose
vasopressin
-‐
no
effect
on
vasopressin
levels
45. B
blockers
in
sepCc
shock
• Open
label,
single
unit
• SepCc
shock
+
HR
≥
95
+
NADR
• 77
paCents
–
esmolol
infusion
(HR
80-‐94)
vs
77
paCents
standard
treatment
• Esmolol
group
– 28d
Mortality
50%
vs
81%
in
placebo
– Improved
SV
index,
LVSWI,
lactate
– Less
NADR
requirement
– Less
fluid
requirement
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
46. CirculaCon
Sepsis
&
EGDT
ProMISe
–
UK
–
soon…
ARISE
–
Australia
–
ESICM
2014
ProCESS
–
US
-‐
complete
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
47. ProCESS
• RCT
31
ICUs
in
US
• 03/2008
–
05/2013
• 1351
paCents
with
sepCc
shock
• 3
groups
– EGDT
– Protocol
based
standard
therapy
– Usual
care
– No
difference
in
60
d
mortality
between
groups
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
48. IVOIRE
Study
• Randomised,
open
study
• 18
ICU’s
in
France,
Belgium
and
Netherlands
2005-‐2010
• 140
pts
with
sepCc
shock
&
AKI
• HVHF
70mls/kg/hr
v
35mls/kg/hr
• Slow
recruitment
• No
difference
in
mortality
=
40%
28/7
• HVHF
not
recommended
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
49. Fluids
• Don’t
give
too
much
• Don’t
give
too
liRle
• Make
sure
you
give
the
right
amount
• Starches
bad…very
bad
AssociaCon
of
HES
administraCon
with
mortality
and
AKI
in
criCcally
ill
paCents
requiring
volume
resuscitaCon.
Meta-‐
analysis.
JAMA
2013
vol
309
(7)
• Albumin
back
in?
SAFE
subgroup
analysis
1200
pts
with
severe
sepsis
-‐
28/7
mortality
lower
in
albumin
group
(30%
vs.
35%
OR
0.87)
Finfer
S
et
al
2011
Intensive
Care
Med
37:86–96
Delayney
metaanalysis.
Role
of
albumin
as
a
resuscita;on
fluid
for
pa;ents
with
sepsis.
17
studies,
1977
pa;ents.
Crit
Care
Med
2011
Albios
Study
–
GaXnoni
(video
ion
ESICM
website)
“lets
talk
about
fluid
responsiveness”
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
50. ALBIOS
• RCT,
100
ICUs
in
Italy
• Aug
2008
–
Feb
2012
• 1818
paCents
with
severe
sepsis
• 300mls
20%
HAS
daily
to
maintain
serum
albumin
at
30g/dl
+
CSL
vs.
CSL
• Primary
outcome:
mortality
at
28d
– HAS
+
CSL:
31.8%
– CSL:
32%
• Secondary
outcomes:
90
d
mortality
– No
difference
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
51. 6S
Study
• 804
ICU
pts
with
severe
sepsis
• Compared
fluid
resuscitaCon
– 130/0.4
hydroxyethyl
starch
(tetraspan)
vs
Ringer's
acetate
• HES
associated
with
– Increased
90
day
mortality
51%
vs
43%
– Increased
RRT
requirement
22%
vs
16%
– Trend
for
increased
bleeding
10%
vs
6%
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
52. CHEST
Study
• 7000
ICU
pts
• Fluid
resuscitaCon
with
6%
HES
130/0.4
(Voluven)
or
0.9%
saline
• No
differences
in
– Mortality
(HES
18%
vs
17%)
– LOS
–
ICU
/
Hospital
• HES
associated
with
increased
– RRT
(7%
vs
5.8%;
RR
1.21)
– Pruritus
/
Rash
/
HepaCc
failure
-‐
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
53. CRISTAL
Study
• 2857
sequenCal
ICU
paCents
2003-‐2012
57
ICU’s
• Colloids
vs
CSL
for
all
fluid
intervenCons
other
than
maintenance
• Colloids
– Reduced
mortality
at
28d
&
90d
(25%
vs
27%
&
30%
vs
34%)
– More
days
alive
without
MV
– More
days
alive
without
vasopressors
– Less
RRT
Academic Department of Critical Care
-‐
Queen Alexandra Hospital Portsmouth
55. ESICM
statement
on
colloids
1.
Recommend
not
to
use
HES
with
mw
≥
200kDa
in
paCents
with
severe
sepsis
or
risk
of
AKI
2.
Suggest
avoid
6%
HES
or
gelaCn
in
these
groups
3.
Recommend
not
to
use
colloids
in
paCents
with
head
injury
and
not
to
administer
gelaCns
and
HES
in
orhan
donors
4.
Suggest
avoid
hyperoncoCc
soluCons
for
fluid
resuscitaCon
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
58. TXA
" CRASH
-‐
2
Lancet
2010
• tranexamic
acid
in
reducing
transfusion
requirements
and
death
from
significant
haemorrhage
following
injury
• 20,000
paCents
• Risk
of
haemorrhage
reduced
by
0.8%
• No
reducCon
in
transfusion
usage
• Only
50%
received
blood
and
average
only
3
(?
‘significant
haemorrhage’)
" CRASH
-‐
2
subanalysis
Lancet
2011
• Mortality
directly
related
to
haemorrhage
• Tranexamic
acid
only
effecCve
if
within
first
3
hours.
Beyond
this
Cme
mortality
increases
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
59. TXA
" CRASH
–
2
Does
TXA
reduce
the
risk
of
intracranial
bleeding
in
pa4ents
with
TBI?
BMJ
2011
• 250
of
the
20,000
paCents
eligible.
• Brain
haemorrhage
growth
5mm
vs.
8mm
(TXA
vs.
placebo)
• Not
SS
• No
menCon
of
extent
of
extracranial
injuries
in
either
group
making
mortality
comparisons
difficult
• Not
well
matched
as
there
were
more
pts
with
SAH
(61%
vs
43%)
• No
increase
is
focal
cerebral
ischaemia
• Conclusion
“it
is
probable
that
benefits
of
tranexamic
acid
outweigh
risks’
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
60. Trauma
Haemorrhage
1.
CoagulaCon
monitoring
and
measures
to
support
coagulaCon
should
be
implemented
early
2.
Damage
control
surgery
3.
Physiological
targets,
suggested
use
&
dosing
of
fluids,
blood
products
and
TXA
4.
PaCents
on
anCplatelet
agents
and/or
oral
anCcoagulants
require
special
aRenCon
5.
Mutlidisciplinary
approach
&
evidence
based
protocols
adapted
to
local
circumstances
need
to
be
developed
and
implemented
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
61. Neuro-‐ICU
ICP
Monitoring
• MulCcentre
RCT
of
324
paCents
Bolivia
and
Ecuador
• Intraparenchymal
ICP
monitoring
vs.
clinical
&
imaging
• No
difference
in
mortality
or
neuropsycholoigcal
status
at
6/12
A
Trial
of
Intracranial-‐Pressure
Monitoring
in
TraumaCc
Brain
Injury
Randall
M.
Chesnut
et
al
N
Engl
J
Med
2012;
367:2471-‐2481
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
63. CATIS
• 4,071
paCents
• Within
48
hrs
ischaemic
stroke
• nonthrombolysed
and
↑BP
• Hypertension
therapy
vs
no
BP
Rx
• BP
control
effecCve
• No
difference
– death
and
major
disability
• 14
days
/
hospital
discharge
• 3
months
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
64. INTERACT
2
• 2,839
pts
with
early
spontaneous
intracerebral
haemorrhage
&
↑SBP
• Compared
SBP
<140
mmHg
vs
<180
• Aggressive
BP
control
associated
with
– Trend
for
less
adverse
events
(p=0.06)
– Lower
modified
Rankin
scores
• No
difference
in
mortality
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
65. Magnesium
for
aneurysmal
SAH
(MASH-‐2):
a
randomised
placebo-‐controlled
trial
Mees
S
et
al.
2012
The
Lancet.
Vol
380
9834:44-‐49
• 8
ICU’s
in
Europe
and
S
America
• 1204
paCents
• The
quesCon:
does
Mg
reduce
poor
outcome
by
reducing
vasospasm
and
delayed
cerebral
ischaemia
(DCI)
• Magnesium
64mmol/day
for
20/7
or
placebo
• Primary
outcome
of
poor
outcomes
as
defined
by
score
4-‐5
on
modified
Rankin
Scale
at
3/12,
or
death
• NO
DIFFERENCE
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
66. Delirium
HOPE
ICU
• 142
paCents
with
delirium
• CAM-‐ICU
assessment
• Double
blinded
• Haloperidol
vs.
placebo
• No
change
in
duraCon
of
delirium
in
criCcally
ill
paCents
• Haloperidol
should
be
reserved
for
short
term
management
on
acute
agitaCon
Effect
of
intravenous
haloperidol
on
the
dura4on
of
delirium
and
coma
in
cri4cally
ill
pa4ents
(Hope-‐ICU):
a
randomised,
double-‐blind,
placebo-‐controlled
trial
Valeirie
Page.
The
Lancet
Respiratory
Medicine,
Volume
1,
Issue
7,
Pages
515
-‐
523,
September
2013
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
67. TreaCng
delerium
101
MV
pa4ents
RCT
haloperidol
vs.
ziprasidone
vs
placebo
21/7
study
period
No
difference
in
any
of
the
groups!
68. The
beginning;
Kress
NEJM
2000
ReducCon
in
LOS
Girard
Lancet
2008
Decreased
ICU
stay,
Cme
on
venClator
and
mortality
Strom
Lancet
2010
ReducCon
in
LOS
and
venClator
days
No
sedaCon
group
-‐
boluses
of
morphine,
well
established
in
insCtuCon,
more
agitated
delerium
in
no
sedaCon
group
Ryker
JAMA
2009
ReducCon
in
venClator
days
and
delirium
Jacob
JAMA
2012
PRODEX/MIDEX
No
beRer
than
midaz
or
propofol
at
maintaining
light
to
mod
sedaCon
and
more
adverse
effects.
Increased
paCent
interacCons.
Less
vent
days
than
midazolam
Mehta
2013
For
MV
paCents
managed
with
protocolised
sedaCon,
the
additon
of
daily
sedaCon
interrupCon
did
not
reduce
duraCon
MV
or
ICU
LOS
69. The
beginning;
Kress
NEJM
2000
ReducCon
in
LOS
Girard
Lancet
2008
Decreased
ICU
stay,
Cme
on
venClator
and
mortality
Strom
Lancet
2010
ReducCon
in
LOS
and
venClator
days
No
sedaCon
group
-‐
boluses
of
morphine,
well
established
in
insCtuCon,
more
agitated
delerium
in
no
sedaCon
group
Ryker
JAMA
2009
ReducCon
in
venClator
days
and
delirium
Jacob
JAMA
2012
PRODEX/MIDEX
No
beRer
than
midaz
or
propofol
at
maintaining
light
to
mod
sedaCon
and
more
adverse
effects.
Increased
paCent
interacCons.
Less
vent
days
than
midazolam
Mehta
2013
For
MV
paCents
managed
with
protocolised
sedaCon,
the
additon
of
daily
sedaCon
interrupCon
did
not
reduce
duraCon
MV
or
ICU
LOS
70. Don’t
forget
the
simple
things….
• Small
RCT
136
paCents
• Used
NEECHAM
score
• Delirium
(20%)
similar
but
less
mild
confusion
with
ear
plugs
and
good
night
sleep
<50%
vs.
25%
71. Guidelines
for
managing
delirium
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
73. Acute
UGI
Bleed
• Randomised,
parallel
group
study
• 921
pts
with
severe
upper
GI
bleeding
• Compared
restricCve
(Hb
<7g/dL)
vs
liberal
transfusion
strategy
(Hb<9g/dL)
• RestricCve
strategy
associated
with
– Reduced
number
of
pts
receiving
transfusion
(15%
vs
51%)
– Increased
probability
survival
(HR
0.55)
– Less
rebleeding
(10%
vs
16%)
– Less
adverse
events
(40%
vs
48%)
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
75. The
SuDDICU
study
SDD
12
meta-‐analyses
of
28
RCT’s.
10
show
reduced
pneumonia
rate;
6
show
morality
benefit
• Why
have
clinicians
avoided
implemenCng
it
in
UK?
• What
are
the
barriers?
• What
further
evidence
is
required
before
full
scale
clinical
implementaCon
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
76. SystemaCc
review:
CCM
2010
• Those
paCents
receiving
enteral
nutriCon,
stress
ulcer
prophylaxis
may
not
be
required
and
may
actually
increase
VAP
77. H2R
antagonists
vs
PPI
• Cohort
Study
of
35,000
pts
• MV
>
24
hours
and
either
H2R
antagonist
or
PPI
• H2R
antagonist
group
had
– Less
GI
haemorrhage
2.1
vs
5.9%
– Pneumonia
27%
vs
39%
– C.Diff
2.2%
vs
3.8%
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
78. Hepatology
• ALD
" Alcohol
related
illness
costs
NHS
£1.7
billion/year
" SystemaCc
review
of
21
arCcles
" Overall
ICU
mortality
40-‐50%
" Mackle
study
only
one
to
provide
data
on
GI
haemorrhage
-‐
mortality
48%,
62%,
67%,68%
for
unit,
hospital,
6/12
and
one
yr
-‐
if
get
out
of
hospital
most
will
survive
" Organ
support
-‐
3
papers
(venClaCon,
vasoacCve
drugs,
RRT)
" Mackle
-‐
-‐ if
MV
and
vasoacCve
drugs
hospital
mortality
86%
-‐ If
MV,
vasoacCve
drugs
and
RRT
>
90%
-‐ If
just
MV
31%
" Saliba
RRT
90%
" Rye
100%
mortality
if
require
RRT
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
80. FuncConal
disability
5
years
aeer
ARDS
" 109
survivors
from
’98
-‐
’01
" Interview,
PFT’s,
6
min
walk
test,
resCng
&
exercise
oximetry,
chest
imaging,
QOL
survey
" PFT’s
normalish
" BUT
6
min
walk
test
76%
predicted,
physical/
psychological
problems
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
82. Suggested
resources
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
• JICS
• Sign
up
to
criCcalcarereviews.com
• Podcasts
• LITFL
• FFICM
&
ICS
83. Best
of
Luck!
Academic Department of Critical Care
Queen Alexandra Hospital Portsmouth
www.wessexics.com
@WessexICS
@WICSBoRomLine
@stevemathieu75